Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (131-140 of 4,096) with videos related to

Pageof 410
Sort By:
Cancer Cell|May 13, 2020
Cancer Research after COVID-19: Where Do We Go from Here?Lauren E Colbert, Ramez Kouzy, Joseph Abi Jaoude, et al.
Cancer Cell|September 14, 2021
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitorKevin Freeman-Cook, Robert L Hoffman, Nichol Miller, et al.
Cancer Cell|August 27, 2021
Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancerMario Mairhofer, Lea Kausche, Sabine Kaltenbrunner, et al.
Cancer Cell|August 29, 2025
Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancerJennifer R Grandis, Katherine A Skorupski, Ning Cheng, et al.
Cancer Cell|August 29, 2025
Glioblastoma hijacks cholinergic networksYen Vu, Moran Amit
Cancer Cell|April 25, 2020
C/EBPα and GATA-2 Mutations Induce Bilineage Acute Erythroid Leukemia through Transformation of a Neomorphic Neutrophil-Erythroid ProgenitorCristina Di Genua, Simona Valletta, Mario Buono, et al.
Cancer Cell|April 15, 2020
Intratumor Heterogeneity: The Rosetta Stone of Therapy ResistanceAndriy Marusyk, Michalina Janiszewska, Kornelia Polyak
Cancer Cell|April 15, 2020
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic ImplicationsGeorge W Wright, Da Wei Huang, James D Phelan, et al.
Cancer Cell|August 10, 2021
Tumor heterogeneityDana Pe'er, Seishi Ogawa, Ofer Elhanani, et al.
Cancer Cell|August 10, 2021
Is resistance to targeted therapy in cancer inevitable?Lorey K Smith, Karen E Sheppard, Grant A McArthur
Pageof 410

Showing results (131-140 of 4,096) with videos related to

Sort By:
Pageof 410
Cancer Cell|May 13, 2020
Cancer Research after COVID-19: Where Do We Go from Here?Lauren E Colbert, Ramez Kouzy, Joseph Abi Jaoude, et al.
Cancer Cell|September 14, 2021
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitorKevin Freeman-Cook, Robert L Hoffman, Nichol Miller, et al.
Cancer Cell|August 27, 2021
Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancerMario Mairhofer, Lea Kausche, Sabine Kaltenbrunner, et al.
Cancer Cell|August 29, 2025
Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancerJennifer R Grandis, Katherine A Skorupski, Ning Cheng, et al.
Cancer Cell|August 29, 2025
Glioblastoma hijacks cholinergic networksYen Vu, Moran Amit
Cancer Cell|April 25, 2020
C/EBPα and GATA-2 Mutations Induce Bilineage Acute Erythroid Leukemia through Transformation of a Neomorphic Neutrophil-Erythroid ProgenitorCristina Di Genua, Simona Valletta, Mario Buono, et al.
Cancer Cell|April 15, 2020
Intratumor Heterogeneity: The Rosetta Stone of Therapy ResistanceAndriy Marusyk, Michalina Janiszewska, Kornelia Polyak
Cancer Cell|April 15, 2020
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic ImplicationsGeorge W Wright, Da Wei Huang, James D Phelan, et al.
Cancer Cell|August 10, 2021
Tumor heterogeneityDana Pe'er, Seishi Ogawa, Ofer Elhanani, et al.
Cancer Cell|August 10, 2021
Is resistance to targeted therapy in cancer inevitable?Lorey K Smith, Karen E Sheppard, Grant A McArthur
Pageof 410